An Observational Study on the Relationship Between Tear Metabolomics and POD

To explore the correlation between tear metabolomics and POD. The purpose of this study was to compare the results of tear metabolomics between POD and non-POD elderly patients undergoing abdominal surgery, to clarify the correlation between tear metabolomics and POD, and to find tear markers related to POD.

Study Overview

Status

Completed

Study Type

Observational

Enrollment (Actual)

150

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Chongqing
      • Chongqing, Chongqing, China, 400010
        • Department of Anesthesiology, The Second Affiliated Hospital, Chongqing Medical University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years to 90 years (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

In the elderly patients who underwent abdominal surgery under general anesthesia, there were no serious systemic diseases and severe cognitive impairment before operation.

Description

Inclusion Criteria:

  • age 65-90 years old;
  • ASA I-III;
  • patients who plan to undergo elective abdominal surgery under general anesthesia;
  • Volunteer to participate in this study and sign informed consent.

Exclusion Criteria:

  • patients with known mental illness or lack of communication or cognitive impairment before operation;
  • severe vision, hearing, language impairment or other reasons unable to communicate with visitors;
  • severe dysfunction of important organs such as heart, brain, lung, liver, kidney, etc.;
  • long-term use of sedatives, antidepressants or alcoholism;
  • patients with severe postoperative complications and admitted to intensive care unit;
  • patients who refused or failed to complete the cognitive function test.
  • patients who could not cooperate with the study for any other reason

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative delirium during the 3 adys-follow-up after anesthetic resuscitation
Time Frame: From ending of the surgery to 3 days after anesthetic resuscitation
Postoperative delirium was tested with 3D-Confusion Assessment Method or Confusion Assessment Method-intensive care unit (0-4, higher scores means worse). The patient is determined to be postoperative delirium (ie, Confusion Assessment Method positive) if he/she fall ill quickly with confusion disorder, and with mental disorder or consciousness disorder.
From ending of the surgery to 3 days after anesthetic resuscitation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative delirium in the postanesthesia care unit
Time Frame: From ending of the surgery to the time when discharge from postanesthesia care unit, an average of 30 minutes.
Postoperative delirium was tested with Confusion Assessment Method-intensive care unit. Postoperative delirium was tested with Confusion Assessment Method-intensive care unit (0-4, higher scores means worse outcome). The patient is determined to be postoperative delirium (ie, Confusion Assessment Method positive) if he/she fall ill quickly with confusion disorder, and with mental disorder or consciousness disorder.
From ending of the surgery to the time when discharge from postanesthesia care unit, an average of 30 minutes.
Postoperative delirium on the first day after operation
Time Frame: 9:00-10:00 and 15:00-16:00 on The first day after operation
Postoperative delirium was tested with 3D-Confusion Assessment Method (0-4, higher scores means worse outcome). The patient is determined to be postoperative delirium (ie, Confusion Assessment Method positive) if he/she fall ill quickly with confusion disorder, and with mental disorder or consciousness disorder.
9:00-10:00 and 15:00-16:00 on The first day after operation
Postoperative delirium on the second day after operation
Time Frame: 9:00-10:00 and 15:00-16:00 on The second day after operation
Postoperative delirium was tested with 3D-Confusion Assessment Method (0-4, higher scores means worse outcome). The patient is determined to be postoperative delirium (ie, Confusion Assessment Method positive) if he/she fall ill quickly with confusion disorder, and with mental disorder or consciousness disorder.
9:00-10:00 and 15:00-16:00 on The second day after operation
Postoperative delirium on the third day after operation
Time Frame: 9:00-10:00 and 15:00-16:00 on The third day after operation
Postoperative delirium was tested with 3D-Confusion Assessment Method (0-4, higher scores means worse outcome). The patient is determined to be postoperative delirium (ie, Confusion Assessment Method positive) if he/she fall ill quickly with confusion disorder, and with mental disorder or consciousness disorder.
9:00-10:00 and 15:00-16:00 on The third day after operation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Huang He, MD, Department of Anesthesiology, The Second Affiliated Hospital, Chongqing Medical University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 22, 2022

Primary Completion (Actual)

March 1, 2023

Study Completion (Actual)

March 1, 2023

Study Registration Dates

First Submitted

September 6, 2022

First Submitted That Met QC Criteria

September 16, 2022

First Posted (Actual)

September 21, 2022

Study Record Updates

Last Update Posted (Actual)

March 29, 2023

Last Update Submitted That Met QC Criteria

March 28, 2023

Last Verified

December 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The individual participant data for this study is available from the sponsor on reasonable request through email

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Delirium

Subscribe